Skip to main content
. 2022 May 18;13(1):37–53. doi: 10.1007/s13346-022-01179-6

Table 1.

Drug delivery considerations with gastric surgical procedures

Physiological impact Gastric surgical procedure Drug delivery considerations
Dumping syndrome

▪  Parietal cell vagotomy is associated with less frequency of the dumping syndrome in comparison to truncal vagotomy

▪  Resection of the pylorus can accelerate gastric emptying

▪  Dumping syndrome is a common complication of bariatric surgery (esp. RYGB and BPD)

▪  May affect drug formulations that are dependent on gastrointestinal transit time to trigger drug release, leading to reduce efficacy
Increased gastric pH

▪  Gastrectomy can lead to the production of less hydrochloric acid

▪  Surgical procedures that interfere with pyloric function may lead to reflux of alkaline duodenal fluid into the stomach

▪  May reduce the absorption of drugs that require an acidic environment for dissolution

▪  May trigger premature release of drugs from formulations that have pH-responsive coatings or matrices

Post-surgery diarrhea

▪  Truncal vagotomy may cause diarrhea (episodic or persistent)

▪  Bariatric surgery may cause diarrhea (e.g., diet high in fat can lead to diarrhea following BPD procedure)

▪  May reduce the time available for drug absorption

▪  May cause inefficient release of drugs from formulations that are dependent on gastrointestinal transit time

▪  Can affect other physiological factors in the gastrointestinal tract (e.g., intestinal volume, pH, mucosal integrity, and resident microbiome)

Chronic gastroparesis ▪  Gastroparesis can occur post-vagotomy when the vagus nerve is damaged

▪  May affect the time available for disintegration, dissolution, and/or drug absorption

▪  Premature drug release may occur in the stomach due to the prolonged gastric transit time

Anastomoses

▪  Gastric surgery with anastomoses is common with bariatric surgery (e.g., RYGB and BPD)

▪  Anastomoses may also be needed following other gastrectomy procedures to ensure alimentary continuity

▪  Until the anastomoses are healed, drugs should be delivered in their immediate-release formulation and ideally in a liquid dosage form or crushed

▪  After anastomoses are healed, whole pills can be administered (< 11 mm in size)

▪  Consider other routes of drug administration